ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 135758 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 135758; 2) Community: the network communities that were significantly associated with the response to NSC 135758; 3) Molecule: the relationships between components within communities and NSC 135758; 4) MDR: the compounds that were significantly associated with the NSC 135758.

NSC Compound Enrichment Correlation
NSC 58573 Pyrimidine, 2,4,5-trichloro-6-ethyl- 0.00352002370824893 0.065799228
NSC 629971 Camptothecin Derivative 0.00352002370824893 0.80829308
NSC 70931 2-Picenecarboxylic acid, 1,2,3,4,4a,5,6,6a,11,12b,13,14,14a,14b-tetradecahydro-10-hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo- 0.00352002370824893 -0.027718582
NSC 76150 Null 0.00352002370824893 0.28800819
NSC 105014 Cladribine 0.00407837248037199 0.49402069
NSC 132313 Dianhydrogalactitol 0.00407837248037199 0.91569767
NSC 45236 Null 0.00407837248037205 0.19586816
NSC 606497 Camptothecin Derivative 0.00407837248037205 0.87170217
NSC 673787 Null 0.00407837248037205 0.10241193
NSC 678869 Benz[a]anthracene-6,6-dicarboxylic acid, 5,6,7,12- tetrahydro-2-methoxy-7,12-dioxo-, dimethyl ester 0.00407837248037205 0.14035921
Total:49  Current:6    [First] [Prev] [Next] [Last]